Literature DB >> 30685787

Renal ischemia-reperfusion injury impairs renal calcium, magnesium, and phosphate handling in mice.

Manuel Meurer1, Klaus Höcherl2.   

Abstract

Fibroblast growth factor 23 (FGF23) levels are elevated in patients with acute kidney injury (AKI). The consequences on renal Ca2+, Mg2+, and Pi regulatory mechanisms are unknown. We hypothesized that renal ischemia-reperfusion (I/R) injury alters the expression of important renal Ca2+, Mg2+, and Pi transport proteins. I/R injury was induced in male C57BL/6 mice by clamping both renal arteries for 27 min. Mice were investigated 18 h later. The mRNA and protein levels of renal Ca2+, Mg2+, and Pi transport proteins were measured by RT-qPCR and western blot analysis. I/R injury-induced hyperphosphatemia and hypermagnesemia were paralleled by a decrease in glomerular filtration rate and an increase in the fractional excretion of Ca2+, Mg2+, and Pi. I/R injury affected the fibroblast growth factor 23 (FGF23)-klotho-vitamin D axis by increasing plasma levels of FGF23 and downregulation of renal klotho expression. Plasma levels of PTH and 1,25-dihydroxyvitamin D3 were unchanged. Further, downregulation of key genes for paracellular reabsorption of Ca2+ and Mg2+ (claudin (Cldn)2, Cldn10b, Cldn16, Cldn19) and for active transcellular transport of Ca2+, Mg2+, and Pi (calbindin-D28K, Ncx1, Pmca4, Cnnm2, Trpm7, NaPi-2a, and NaPi-2c) was observed. However, renal expression of Trpv5 and Trpv6 was increased. In vitro studies support a direct effect of proinflammatory cytokines on the mRNA expression of Cldn16, Cldn19, and Trpv6. Our findings indicate that renal I/R injury increases FGF23 blood levels independent of PTH and 1,25-dihydroxyvitamin D3. This increase is associated with hypermagnesemia, hyperphosphatemia, and increased or decreased expression of specific renal Ca2+, Mg2+, and Pi transporters, respectively.

Entities:  

Keywords:  Acute kidney injury; FGF23; Inflammation; Klotho; Parathyroid hormone

Mesh:

Substances:

Year:  2019        PMID: 30685787     DOI: 10.1007/s00424-019-02255-6

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  68 in total

1.  Expression of transient receptor potential melastatin 7 up-regulated in the early stage of renal ischemia-reperfusion.

Authors:  Z Meng; X Wang; Z Yang; F Xiang
Journal:  Transplant Proc       Date:  2012-06       Impact factor: 1.066

2.  Endotoxaemia differentially regulates the expression of renal Ca2+ transport proteins in mice.

Authors:  Manuel Meurer; Klaus Höcherl
Journal:  Acta Physiol (Oxf)       Date:  2018-09-03       Impact factor: 6.311

Review 3.  Progression from acute kidney injury to chronic kidney disease: clinical and experimental insights and queries.

Authors:  Richard A Zager
Journal:  Nephron Clin Pract       Date:  2014-09-24

Review 4.  Biomarkers in acute kidney injury - pathophysiological basis and clinical performance.

Authors:  E V Schrezenmeier; J Barasch; K Budde; T Westhoff; K M Schmidt-Ott
Journal:  Acta Physiol (Oxf)       Date:  2016-08-25       Impact factor: 6.311

5.  The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB.

Authors:  Juan A Moreno; Maria C Izquierdo; Maria D Sanchez-Niño; Beatriz Suárez-Alvarez; Carlos Lopez-Larrea; Aniela Jakubowski; Julia Blanco; Rafael Ramirez; Rafael Selgas; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz; Ana B Sanz
Journal:  J Am Soc Nephrol       Date:  2011-06-30       Impact factor: 10.121

6.  Klotho prevents renal calcium loss.

Authors:  R Todd Alexander; Titia E Woudenberg-Vrenken; Jan Buurman; Henry Dijkman; Bram C J van der Eerden; Johannes P T M van Leeuwen; René J Bindels; Joost G Hoenderop
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

7.  Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules.

Authors:  S A Kempson; M Lötscher; B Kaissling; J Biber; H Murer; M Levi
Journal:  Am J Physiol       Date:  1995-04

8.  Fibroblast Growth Factor 23 Expression Is Increased in Multiple Organs in Mice With Folic Acid-Induced Acute Kidney Injury.

Authors:  Daniela Egli-Spichtig; Martin Y H Zhang; Farzana Perwad
Journal:  Front Physiol       Date:  2018-10-23       Impact factor: 4.566

9.  Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy.

Authors:  Su-Young Jung; Jaeyeol Kwon; Seohyun Park; Jong Hyun Jhee; Hae-Ryong Yun; HyoungNae Kim; Youn Kyung Kee; Chang-Yun Yoon; Tae-Ik Chang; Ea Wha Kang; Jung Tak Park; Tae-Hyun Yoo; Shin-Wook Kang; Seung Hyeok Han
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

10.  TRPM7 in CHBP-induced renoprotection upon ischemia reperfusion-related injury.

Authors:  Aifen Liu; Jing Wu; Cheng Yang; Yuanyuan Wu; Yufang Zhang; Fengbo Zhao; Hui Wang; Li Yuan; Lirui Song; Tongyu Zhu; Yaping Fan; Bin Yang
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

View more
  4 in total

1.  Conivaptan and Boric Acid Treatments in Acute Kidney Injury: Is This Combination Effective and Safe?

Authors:  Betül Can; Fatih Kar; Ezgi Kar; Mete Özkoç; Hakan Şentürk; Dilek Burukoğlu Dönmez; Güngör Kanbak; İbrahim Özkan Alataş
Journal:  Biol Trace Elem Res       Date:  2021-10-21       Impact factor: 3.738

Review 2.  Acute Kidney Injury and Pediatric Bone Health.

Authors:  Anisha Hegde; Michelle R Denburg; Dorey A Glenn
Journal:  Front Pediatr       Date:  2021-02-09       Impact factor: 3.418

3.  Potential Protective Role of TRPM7 and Involvement of PKC/ERK Pathway in Blue Light-Induced Apoptosis in Retinal Pigment Epithelium Cells in Vitro.

Authors:  Luping Hu; Guoxing Xu
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2021-11-16

4.  Calpain Inhibitor Calpeptin Alleviates Ischemia/Reperfusion-Induced Acute Kidney Injury via Suppressing AIM2 Inflammasome and Upregulating Klotho Protein.

Authors:  Yong Wu; Huan Yang; Ming Cheng; Jialin Shi; Weichen Zhang; Shaojun Liu; Minmin Zhang
Journal:  Front Med (Lausanne)       Date:  2022-01-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.